Carter's (CRI)
(Delayed Data from NYSE)
$23.65 USD
-0.59 (-2.43%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $23.65 0.00 (0.00%) 7:58 PM ET
5-Strong Sell of 5 5
A Value A Growth C Momentum A VGM
Fundamental Charts
About Market Cap
As of the previous market close, Carter's, Inc. has a market cap of $883.12M, which represents its share price of $24.24 multiplied by its outstanding shares number of 36.43M. As a small-cap company, CRI's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
CRI 23.65 -0.59(-2.43%)
Will CRI be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CRI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CRI
Carter's Q2 Earnings Miss Estimates, Stock Dips After Tariff Concerns
Carter's (CRI) Misses Q2 Earnings Estimates
CRI: What are Zacks experts saying now?
Zacks Private Portfolio Services
What Should Investors Expect From Carter's Ahead of Q2 Earnings?
Nike (NKE) Tops Q4 Earnings and Revenue Estimates
NIKE Stock Slides Below 50-Day SMA: Buy Opportunity or Risky Affair?
Other News for CRI
1 Company Who Recently Cut Its Dividend By 69%, And 1 Who Could Potentially Cut In The Near Future
Carter's (CRI) Stock: Barclays Lowers Price Target to $22 | CRI Stock News
Carter's price target lowered by $3 at Barclays, here's why
Carter's (CRI) Target Price Reduced by Barclays Amid Ongoing Concerns
Carter's Q2 Results Were Not Good, And Tariffs' Impact Is Still Incoming